NeuroOne Announces Publication of Clinical Experience with OneRF sEEG-Guided Radiofrequency Ablation Technology

NeuroOne Medical Technologies Corporation has announced the publication of a clinical case series using its OneRF Ablation System for drug-resistant epilepsy patients. The study reports safe integration into existing stereotactic workflows, bedside treatment capability, and reductions in seizure burden in four consecutive patients. The technology enables RF ablation through implanted sEEG electrodes, with real-time temperature monitoring and no adverse events. The publication highlights the system's potential value as a diagnostic and prognostic tool.